Literature DB >> 6415849

Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.

H R Lijnen, B van Hoef, D Collen.   

Abstract

The interaction between heparin, histidine-rich glycoprotein and antithrombin III was studied in purified systems. Histidine-rich glycoprotein binds heparin and thereby interferes with its interaction with antithrombin III, resulting in neutralization of the anticoagulant activity. This interaction occurs with clinical grade heparin as well as with high affinity (for antithrombin III) heparin and with a high affinity heparin fragment with Mr 4,300. Low affinity heparin competes with high affinity heparin for the binding to histidine-rich glycoprotein which results in an apparent increase of the anticoagulant activity of high affinity heparin. The interaction between heparin and histidine-rich glycoprotein is counteracted by Ca2+-binding anticoagulants, indicating that it is dependent on the presence of divalent metal ions. Ethylenediaminetetraacetate is a much more potent inhibitor of the interaction between heparin and histidine-rich glycoprotein than citrate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415849

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

Authors:  Matthew Ndonwi; Oname O Burlingame; Aaron S Miller; Douglas M Tollefsen; George J Broze; Daniel E Goldberg
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

2.  Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin.

Authors:  Peyman Dinarvand; Likui Yang; Indranil Biswas; Hemant Giri; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2020-01-14       Impact factor: 5.824

Review 3.  Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes.

Authors:  Yixiao Pan; Lu Deng; Hai Wang; Kang He; Qiang Xia
Journal:  Genes Dis       Date:  2020-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.